NCT07815483Not yet recruiting
A Multicenter Cohort Study of AI-Based Methods for Pulmonary Nodule Diagnosis and Follow-up
A Prospective, Multicentre Cohort Study of Artificial Intelligence-based Methods for Pulmonary Nodule Segmentation, Benign-Malignant Risk Stratification, and Follow-up
Source: ClinicalTrials.gov · Last updated 11 Sept 2026
Brief summary (registry, in English)
This is an observational, multicentre study. The primary objective of this study was to evaluate the diagnostic performance and clinical applicability of artificial intelligence models for pulmonary nodule segmentation, benign-malignant risk stratification, and follow-up management. We will collect CT images and medical data from participants at several hospitals. Participants will not receive any drugs or medical interventions.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 16880 (estimated)
- First submitted
- 8 Sept 2026
- Start date
- Oct 2026
- Primary completion date
- Oct 2028
- Lead sponsor
- Shanghai East Hospital
- Diseases
- Lung cancer
- NCT number
- NCT07815483
What you commit to
- Study type: Observational
- Planned participants: 16880
- From Oct 2026 to the primary completion date, Oct 2028
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- History of prior ipsilateral lung malignancy or local treatment. -
Other
- Poor CT image quality with severe artifacts that preclude AI-based analysis;
- Expected survival \<12 months or inability to complete follow-up;
Who the study is looking for
- (1) Age ≥18 years; (2) At least one non-calcified pulmonary nodule (diameter ≥3 mm and ≤30 mm) detected on chest CT; (3) Agreement to participate in the study and provision of written informed consent.
- \-
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.